Search Results
Results found for "Design Pharmaceuticals"
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
The pharmacological profiles and mechanistic insights of our study provide clues for the future design
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
to PK–PD dissociation, Kenakin equips you with the kinetic models and biological context needed to design
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
MQ1-K39A represents the first step in the improvement of the MQ1 design from a medicinal perspective.
- How Fast Does a Drug Work?
Kenakin’s latest  lecture delivers exclusive, real-world insight designed to equip you to move beyond
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
Logo Contest : Let your creativity shine by submitting your design for the Logo Contest before August
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
At Celtarys, our GPCR fluorescent ligands are designed with a variety of photophysical properties to
- Why “Displacement” Misleads You: Allosteric Binding Demystified
radioligand binding but suppresses functional response, it’s not broken pharmacology—it’s biology working as designed
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
Red-flagging toxicophores accelerates rational design cycles Computational prediction complements biological
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
receptor, which could participate in the recognition of MT1-selective ligands and may be exploited in the design
- đź“° GPCR Weekly News, July 3 to 9, 2023
GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs
- How Schild Analysis Protects Your Conclusions in GPCR Research
GPCR University content, and an integrated view of publications, events, insights, and opportunities designed
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
Methods: To address this question, we studied mice that express a Gs-coupled designer G protein-coupled
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
At Celtarys, we support this transition by offering optimized fluorescent ligands specifically designed
- GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth
Plus 6 industry updates and 1 new Masterclass recording now available — Purinergic GPCR Ligand Design
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
lectures, classified industry news, priority event alerts, job opportunities, and insider commentary—designed
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
beyond natural agonist analogs Awareness of how GPCR allostery and biased signaling are redefining drug design
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
translational research models, further refining his interest in bridging molecular insights with therapeutic design
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
to 10th, 2024 Industry News Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments Five protein-design
- How Collaboration Drives GPCR Discoveries
It will hinge on the teams who can map GPCR signaling with precision and design therapies that fit real
- đź“° GPCR Weekly News, June 19 to 25, 2023
Methods & Updates in GPCR Research A coiled-coil-based design strategy for the thermostabilization of
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
Altogether, these aspects hint that the linker design and strategy can provide options for the tuning Structure-Based Design of High-Affinity Fluorescent Probes for the Neuropeptide Y Y1 Receptor. J. An Order of Magnitude Faster DNA-PAINT Imaging by Optimized Sequence Design and Buffer Conditions.
- đź“° GPCR Weekly News, May 22 to 28, 2023
GPCR Binders, Drugs, and more Design of Drug Efficacy Guided by Free Energy Simulations of the β2 -Adrenoceptor
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
, Activation, and Signaling Pathways in the Brain An understanding of GPCR structure is key in drug design
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
is of great importance in GPCRs field as it supports the development of alternatives to improve drug design
- đź“° GPCR Weekly News, January 23 to 29, 2023
Design, synthesis, and evaluation of substituted alkylindoles that activate G protein-coupled receptors
- đź“° GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
Submit your design for our Logo Contest by August 15, 2024 (Yes, it's TODAY)!
- Quantifying Receptor Selectivity in Modern Drug Discovery
It is designed for: Pharmacologists sharpening foundational tools Discovery teams solving assay bottlenecks
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
Catherine’s work lays the foundation for designing better interventions, from preclinical models to clinical
- đź“° GPCR Weekly News - January 9 to 15, 2023
Modelling altered signalling of G-protein coupled receptors in inflamed environment to advance drug design
- Exploring the Breakthroughs in GPCR Research
Logo Contest:Â Unleash your creativity and submit your design by August 15, 2024.




















